Современные направления в лечении диабетической энцефалопатии [PDF]
ДИАБЕТИЧЕСКИЕ ...
Мироненко, М. О. +1 more
core
[Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the ACE2 gene, and therapy with RAS blockers on the severity of COVID-19]. [PDF]
Zuraeva ZT +8 more
europepmc +1 more source
Pharmacoepidemiological analysis of the drugs used for secondary prevention of brain infarction on dispensary stage [PDF]
Aim. The secondary prevention of cerebral infarction on dispensary stage to current clinical guidelines was analyzed. Adherence of patients to prescribe medications was evaluated. Material and methods.
Furman N.V. +2 more
core
[Effect of bone anabolic therapy on bone remodeling and bone density in geriatric patients with osteoporosis and falling syndrome]. [PDF]
Khovasova NO +5 more
europepmc +1 more source
Изменение фармакокинетики симвастатина при экспериментальном гипотиреозе [PDF]
Результаты исследования, посвященного изучению фармакокинетики симвастатина при экспериментальном гипотиреозе. Эксперимент выполнен на 6 половозрелых кроликахyesРязанский государственный медицинский университет им. акад.
Попова, Н. М. +1 more
core +1 more source
[Two models of insulin resistance development and the strategy to combat age-related diseases: literature review]. [PDF]
Martyushev-Poklad AV +3 more
europepmc +1 more source
MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
The mechanism of myocardial damage in diabetes mellitus is considered. The pathogenesis of myocardial fibrosis, leading to diabetic cardiomyopathy, is described in details.
O. M. Drapkina, B. B. Gegenava
doaj +1 more source
Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus (DM 2) in current clinical practice.Material and methods. A total of 200 patients with DM 2, who consented to take part in the questionnaire, were examined.
I. E. Sapozhnikova +2 more
doaj +1 more source
OBSERVATIONAL TRAILS IN LIPIDOLOGY
Approaches to the evaluation of drug efficacy and safety are discussed. The specifics of clinical and observational trails are presented. The trail data on statins efficacy and safety are held up as a model.
S. A. Shalnova
doaj +1 more source
Изучение качества жизни пациентов с облитерирующим атеросклерозом сосудов нижних конечностей [PDF]
КАЧЕСТВО ЖИЗНИАРТЕРИОСКЛЕРОЗ ОБЛИТЕРИРУЮЩИЙСОСУДЫКОНЕЧНОСТЬ НИЖНЯЯЛИОФИЛИЗАЦИЯЛИОФИЛИЗАТ ...
Антюфриева, Д. А. +2 more
core

